Aberdeenshire, United Kingdom

Francis J Carr

USPTO Granted Patents = 30 

 

Average Co-Inventor Count = 3.6

ph-index = 8

Forward Citations = 474(Granted Patents)


Location History:

  • Balmedle, GB (2008)
  • Aberdeen, GB (2002 - 2018)
  • Aberdeenshire, GB (2007 - 2022)

Company Filing History:


Years Active: 2002-2022

Loading Chart...
Loading Chart...
30 patents (USPTO):Explore Patents

Title: Overview of Francis J Carr – Innovator in Antibody Research

Introduction

Francis J Carr is a prolific inventor based in Aberdeenshire, GB, known for his significant contributions to the field of immunotherapy through his innovative research on antibodies. With an impressive portfolio of 30 patents, Carr’s work has notably impacted the landscape of cancer treatment and diagnostics.

Latest Patents

Among his latest patents is a remarkable invention focused on polynucleotides encoding humanized antibodies against CEACAM1. This invention comprises humanized antibodies that can specifically bind to human CEACAM1 molecules, containing human-to-murine back-mutations in non-CDR variable regions. These antibodies, along with their encoding polynucleotide sequences, are intended for use in pharmaceutical compositions aimed at treating and diagnosing cancer and various other conditions.

Another significant patent involves human anti-PD-1, PD-L1, and PD-L2 antibodies. The present invention is based on the identification of novel antibodies that can diagnose, prognose, and treat conditions that benefit from modulating PD-1, PD-L1, and PD-L2 activity. These conditions include persistent infectious diseases, autoimmune diseases, asthma, transplant rejection, inflammatory disorders, and tumors.

Career Highlights

Carr has worked with notable companies, particularly Merck Patent GmbH, where he contributed to the advancement of pharmaceutical innovation. He also collaborated with Emory University, further enhancing his research capabilities and impact in the scientific community.

Collaborations

Throughout his career, Carr has collaborated with distinguished professionals, including Timothy David Jones and James Peter Gregson. These collaborations have enriched his research endeavors and fostered significant advancements in the field of antibody research.

Conclusion

Francis J Carr continues to leave a profound mark on the science of immunotherapy with his innovative patents and collaborations. His dedication to developing novel antibodies for cancer treatment and diagnostics showcases the pivotal role inventors play in shaping the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…